Alabama lawmakers move transgender treatment, bathroom legislation forward – WVUA 23
trans, transgender flagBy WVUA 23 Digital Reporter Jas Orr Alabama lawmakers are progressing two bills Democrats are calling anti-transgender. The Alabama House of Representatives last month approved a bill that requires public school students to use …
LGBTQ and gender identification
THE RIGHT MOVE
RIKKI MATHAY
I have men and women friends who are gay. Growing up, I saw them as only either gay or lesbian. But with the LGBTQ movement making its way into mainstream media in the past decades, many were introduced to the complexity…
Gender-Affirming Care Isn’t Child Abuse. It Saves Lives
Policies and legislation that seeks to limit gender-affirming care for trans and nonbinary youth are completely divorced from the guidance, recommendation, and research-backed understanding of how beneficial this care can be.
BB Gandanghari shares mammogram experience
BB Gandanghari advises fellow women to keep their breasts’ health in check through mammogram.
Hormone and gut bacteria link may guide better treatment for
Menopause marks the end of a woman’s fertility, but it can also bring about a slew of other — often baffling — changes, from weight gain to brain fog.Arizona State University scientists have found
Study shows the impact of gender-affirming hormone therapy on epigenetic signature of genes
Gender-affirming hormone therapy could influence the way a person’s genes are turned on or off, according to a new study.
LGBTQ-Friendly Health and Wellness Resources in Seattle
Clinic and health care organizations that provide stigma-free medical help for everyone in the queer community, from hormone therapy to free STI testing.
Global Bio-identical Hormone Replacement Therapy Market 2021 Segmentation, Future Business Strategy, Manufacturers Analysis and Forecast by 2027 – corporate ethos
Global Bio-identical Hormone Replacement Therapy Market by MarketsandResearch.biz presents the impre
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer
U.S. FDA Accepts for Priority Review BMS’s Application for Opdivo Plus Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer